Associated Papers
Clinical characteristics of SFTPC gene mutations in children: a single-center experience.
Yang T et al.
Italian Journal of Pediatrics, 2025
40890883 (PubMed )
Supplement: 13052_2025_2101_MOESM3_ESM.doc
Systematic review of drug effects in humans and models with surfactant-processing disease.
Klay D et al.
European Respiratory Review : an Official Journal of the European Respiratory Society, 2018
Recurrent diffuse lung disease due to surfactant protein C deficiency.
Kazzi B et al.
Respiratory Medicine Case Reports, 2018
A novel surfactant protein C mutation resulting in aberrant protein processing and altered subcellular localization causes infantile interstitial lung disease.
Hong D et al.
Pediatric Research, 2017
A novel surfactant protein C gene mutation associated with progressive respiratory failure in infancy.
Litao MK et al.
Pediatric Pulmonology, 2017
A novel surfactant protein C L55F mutation associated with interstitial lung disease alters subcellular localization of proSP-C in A549 cells.
Liu T et al.
Pediatric Research, 2016
SFTPC mutations cause SP-C degradation and aggregate formation without increasing ER stress.
Thurm T et al.
European Journal of Clinical Investigation, 2013
The surfactant protein C mutation A116D alters cellular processing, stress tolerance, surfactant lipid composition, and immune cell activation.
Zarbock R et al.
Bmc Pulmonary Medicine, 2012
Select a paper to view details